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The capsid domain (CA) of the retroviral Gag protein is a major constituent of the virion core. To examine the role of this
protein in M-MuLV morphogenesis and replication, a series of substitution mutations affecting the central region of CA
were introduced into an infectious proviral DNA. The altered DNAs were introduced into cells, and the resulting lines were
analyzed for production of infectious virions. Only one of the replication defective mutants analyzed was blocked in virion
assembly. The remaining mutant DNAs induced the formation and release of particles containing genomic RNA and polymer-
ase protein. The reverse transcriptase associated with these mutant virions was capable of transcribing both minus strand
strong stop and extended DNA products using the endogenous genomic RNA as template in vitro. Upon infection of fresh
cells, however, no viral DNA synthesis could be detected either by Southern analysis or by an RNase protection assay
developed specifically to detect intermediate products of reverse transcription. The results indicate that the bulk of the CA
mutants are blocked before reverse transcription of the viral genome and suggest an important role for the capsid protein
in an early stage of viral replication. q 1996 Academic Press, Inc.
INTRODUCTION tosidase fusion proteins with alterations in the Gag re-
gion indicated that mutations that disrupted the amino-
The gag gene of mammalian retroviruses encodes a terminal two-thirds of CA had a profound effect on incor-
precursor protein that is responsible for the assembly poration into the particle (Hansen et al., 1990; Jones et
and release of the virion particle from infected cells (for al., 1990). Mutations in the M-MuLV capsid protein have
review, see Wills and Craven, 1991). The Moloney murine also been shown to block Gag-Gag multimerization in the
leukemia virus (M-MuLV) Gag precursor (Pr65gag) is yeast two-hybrid system (Alin and Goff, 1996), suggesting
cleaved by the viral protease during and after assembly that some intermolecular contacts can occur within the
(Arcement et al., 1976, 1977; van Zaane et al., 1976) into CA region or can be perturbed by mutations in the region.
four internal structural proteins: MA (p15), p12, CA (p30), Physical studies of virions also suggests that MuLV CA
and NC (p10). The MA protein is associated with the proteins can be induced to form covalently attached di-
virion membrane; the CA protein constitutes the promi- mers (Hansen and Barklis, 1995). In HIV-1, the carboxy-
nent core of the virion (Bolognesi et al., 1973; Burnette terminus of CA has been shown to be important for pro-
et al., 1976); and the NC is tightly bound to the viral ductive virion assembly, as assayed in mammalian and
nucleic acids. Each of these portions of the Gag products insect cell expression systems (Carrierre et al., 1995;
may play distinct roles in assembly, condensation of the Chazal et al., 1994; Dorfman et al., 1994; Hong and Bou-
core, and entry into the host cell during infection. langer, 1993; Jowett et al., 1992; Reicin et al., 1995; von
Very little is known about the functions of the CA do-
Poblotzki et al., 1993), while much of the rest of the capsid
main of Gag. Analysis of divergent retroviruses suggests
coding region is dispensable for particle production
that the CA domains sometimes contain sequences that
(Wang et al., 1994). In Rous sarcoma virus, several as-
play a role in particle assembly (Chazal et al., 1994; Han-
sembly domains (ADs) have been identified by mutagen-
sen et al., 1990; Hsu et al., 1985; Schwartzberg et al.,
esis, but surprisingly, no region essential for assembly
1984; von Poblotzki et al., 1993). However, the required
in COS cells is located in the capsid region (Wang and
assembly domains, if any, within the capsid protein of
Barklis, 1993; Weldon and Wills, 1993; Wills et al., 1994;
different viruses can vary in position and size. Large dele-
Wills and Craven, 1991). Some mutations in CA, however,tions in the central region of the M-MuLV capsid protein
have been found to block assembly and release in cellsprevented release of viral particles (Schwartzberg et al.,
of the normal avian host (Craven et al., 1995).1984). Analysis of the release of M-MuLV gag-b-galac-
The capsid protein contains a sequence motif, referred
to as the major homology region (MHR), which is highly
conserved among the Gag proteins of distantly related1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (212) 305-8692. retroviruses. This 20-amino acid region includes a motif
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(GlnX3GluX7Arg) in which the identity and position of DNAs and bisulfite mutagenesis
three amino acids is absolutely conserved (Wills and
Plasmid pNCA contains a full-length, nonpermutedCraven, 1991). The evolutionary conservation of the MHR
copy of the wild-type M-MuLV proviral DNA in a portionsuggests that it has an important function in retroviral
of pBR322 (Colicelli and Goff, 1988) and was used inreplication, but no distinct role for this motif has been
NIH/3T3 cells. Plasmid pSV/NCA is a derivative of pNCAidentified. In HIV-1, an alteration of the these residues
which includes the SV40 origin of replication inserted inresulted in a decrease in the ratio of fully processed to
the vector and was used for transient transformation ofunprocessed Gag products in the cell lysates, perhaps
COS-1 cells.indicating a role for this region late in particle assembly
To create point mutations, a deletion was first intro-(Dorfman et al., 1994). Replacement of the conserved
duced into the capsid gene of pNCA between the XhoIarginine by alanine had only a moderate effect on viral
site at nt 2009 and the AflII site at nt 2183 by cleavage,particle yield; in this mutant, the core morphology of the
blunting with the Klenow fragment of DNA polymerase I,released particles was aberrant (Mammano et al., 1994).
and religation. This deleted plasmid was used to formAnalysis of mutations in Mason-Pfizer monkey virus
heteroduplex DNAs with pNCA and subjected to bisulfite(MPMV) suggests that changes in the MHR region also
mutagenesis (Peden and Nathans, 1982) as follows.can affect both capsid assembly and infectivity (Stram-
pNCA was cleaved with HindIII, and the deleted plasmidbio-de-Castillia and Hunter, 1992).
was cleaved with EcoRI. The DNAs were mixed, dena-Despite the ability of some capsid mutants to make
tured, and allowed to reanneal, resulting in the formationviral particles, many release only noninfectious virions.
of circular heteroduplexes containing a single-strandedIn M-MuLV, one such capsid mutant was identified and
deletion loop of 174 bp. This mixture was treated withtested for its ability to reverse transcribe the genomic
bisulfite for 20 or 40 min at 377, dialyzed, and introducedRNA into DNA in acutely infected cells (Hsu et al., 1985).
into BD1528, an ung- strain of Escherichia coli, by electro-No viral DNA was synthesized, suggesting that the block
poration. Bacteria transformed by a heteroduplex plas-in replication occurred at an early postentry step, and
mid were detected by screening DNA preparations forperhaps reflecting a defect in virion ‘‘uncoating’’. In sev-
the presence of a mixture of full-length and deletederal other retroviruses, similar CA mutants have been
DNAs, and the full-length species were recovered afteridentified which assemble noninfectious particles (Cra-
retransformation of DH5a bacteria. The DNA sequenceven et al., 1995; Mammano et al., 1994; Strambio-de-
of these clones in the CA region was determined, andCastillia and Hunter, 1992). The morphology of these mu-
base changes resulting in amino acid changes weretant virions was often abnormal, but the incorporation of
identified. A small DNA fragment (XhoI (nt 2001) to BclIviral RNA, the virion content of the Env and Pol proteins,
(nt 3189)) was isolated from each mutant and used toand the ability to carry out reverse transcription in vitro
replace the corresponding fragment of pNCA to removewere all normal. For many of these mutants it is not
any mutations that might have occurred outside the muta-known why the particles are uninfectious.
genized region.To probe the functions of the M-MuLV capsid, we have
generated mutations which might identify critical regions
Transformation of mammalian cellsof this protein involved in virion assembly and infectivity.
The amino acid substitutions lie within the central do- Proviral DNA plasmids were introduced into NIH/3T3
main of the M-MuLV capsid protein, with several affect- cells by the DEAE-dextran procedure (McCutchan and
ing the MHR region. In vivo, about one-third of these Pagano, 1968) and into COS-1 cells by the chloroquine-
mutants were viable and seemingly unaffected by the dextran procedure (Cullen, 1987); both methods allow
mutations. The remaining nonviable mutants were almost transient expression of the proviruses. Stable NIH/3T3
all capable of assembling into virion particles; these viri- producer lines expressing the mutant proviruses were
ons made no detectable viral DNA in vivo, and were generated by cotransformation by the calcium phosphate
thus blocked in very early stages of entry, before reverse procedure (Wigler et al., 1979), using either pMSVhis or
transcription. pSV2neo DNA as the selectable marker plasmid. Recipi-
ent cells were selected with either 5 mM histidinol or 0.4
MATERIALS AND METHODS mg/ml G418. To identify clones stably expressing the M-
MuLV genome, viral Gag proteins were immunoprecipi-Cells, plasmids, and virus
tated from cell lysates as described below.
NIH/3T3 and COS-1 cells were maintained in Dulbec-
co’s modified Eagle medium (DMEM) supplemented with Analysis of viral proteins
50 mg/ml gentamicin and 10% calf serum or 10% fetal
bovine serum, respectively. For infections of NIH/3T3 Monolayers of transformants at near-confluence (4 1
106 cells in 10-cm dishes) were starved for 30 min incells, virions were filtered through a 0.45-mm filter, sup-
plemented with polybrene at a final concentration of 8 DMEM lacking methionine and labeled with 150 mCi of
[35S]methionine in 5 ml of medium for 45 min. The cellsmg/ml, and exposed to cells for 2 hr.
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FIG. 1. Schematic diagram of the M-MuLV genome and the Gag structural proteins. (A) Complete genome of M-MuLV as a linear proviral DNA.
LTR, long terminal repeat. (B) Enlargement of the 5* end of the genome; MA, matrix; CA, capsid; NC, nucleocapsid; PR, protease. (C) Schematic
representation of M-MuLV CA; the conserved major homology region (MHR) is indicated as a stippled box. (D) Amino acid sequence of XhoI–AflII
region. The two residues implicated in N/B-tropism of MuLVs are underlined. Residues altered in this study are indicated in bold face.
were lysed in RIPA buffer (1% Triton X-100, 1% sodium Analysis of preintegrative viral DNA
deoxycholate, 0.1% SDS, 150 mM NaCl, 10 mM Tris–HCl, Virus was harvested from producer cells and used to
1 mM EDTA). The labeled proteins were immunoprecipi- infect NIH/3T3 cells. After 12 hr, low molecular weight
tated with goat anti-capsid serum (NCI 79S-804) and then DNA was isolated (Hirt, 1967) and analyzed for viral
analyzed by electrophoresis on 10% SDS–polyacryl- DNAs. A fraction of the DNA was displayed by electro-
amide gels followed by fluorography. phoresis on a 0.8% agarose gel, transferred to nylon
Virion-associated proteins were labeled by incubating (Southern and Berg, 1982), and hybridized to a labeled
monolayers of producer cells or transiently transfected viral DNA probe.
COS-1 cells (at 48 hr posttransfection) in 5 ml of DMEM RNAase protection assays were used to identify na-
lacking methionine, and 100 mCi of [35S]methionine, for scent reverse transcribed viral DNA in freshly infected
16–24 hr. Labeled virus particles in the medium were cells. Infection and isolation of viral DNA was as above
passed through 0.45-mm filters and isolated by centrifu- (Hirt, 1967) with the addition of an RNase treatment (100
gation (25,000 rpm, 3 hr at 47). The virions were sus- mg/ml for 30 min) followed by several phenol/chloroform
pended in sample buffer, and the proteins were sepa- extractions, ethanol precipitation and suspension of the
rated by electrophoresis on 10% SDS–polyacrylamide final DNA in 10 ml TE. One to two microliters of this DNA
gels and detected by fluorography. was hybridized to a radiolabeled RNA probe (5 1 105
For detection of intracellular Gag proteins by immu- cpm/reaction) overnight at 457, in a final reaction volume
noblotting, unlabeled cell monolayers were washed with of 20 ml (80% formamide, 40 mM PIPES, pH 6.4, 400
phosphate-buffered saline (PBS), harvested in 1 ml of mM NaCl, 1 mM EDTA). Samples were then treated with
PBS, and pelleted in a microcentrifuge. Proteins in the RNase (40 mg/ml ribonuclease A and 2 mg/ml ribo-
pellets were solubilized in RIPA buffer, mixed with elec- nuclease T1; Ambion) in 350 ml of digestion buffer (10
trophoresis sample buffer, boiled for 3 min, and loaded mM Tris–Cl, pH 8, 300 mM NaCl, 5 mM EDTA) for 2 hr
on an SDS–PAGE gel. For the analysis of virion-associ- at 307. The digestion was terminated by adding SDS to
ated proteins, culture medium from stable producer lines a final concentration of 0.5% and proteinase K to 125 mg/
was collected and the virions were collected by centrifu- ml and incubated at 377 for 15 min. The samples were
gation for 10–20 min at 90,000 RPM in a Beckman TL- extracted once with phenol/chloroform, ethanol precipi-
100 ultracentrifuge. Pellets were resuspended in RIPA tated, and resuspended in gel loading buffer (80% for-
buffer and treated as above. After electrophoresis, the mamide, 1 mM EDTA, 0.1% bromophenol blue, and xy-
proteins were transferred to nitrocellulose membranes lene cyanol). Samples were boiled for 3 min and then
and probed with antiserum against capsid (NCI 79S- loaded on a 10% polyacrylamide/urea gel.
804) diluted 1:2000. Secondary peroxidase swine anti- The probe used in this assay was derived from a DNA
goat antibody (Boehringer-Mannheim) was used diluted fragment of pNCA spanning a SacI site (nt 414) to an
1:10,000. Enhanced chemiluminescence (ECL; Amer- MscI site (nt 662) and includes the U5, R, and part of the
sham) was used to develop the blots as described by U3 regions of the M-MuLV long terminal repeats. The
fragment was excised from pNCA and inserted into thethe manufacturer.
AID VY 8060 / 6a1c$$$281 07-31-96 13:35:37 viral AP: Virology
342 ALIN AND GOFF
TABLE 1polylinker of pBluescript. Labeled RNA probes were pre-
pared by incubation of 0.5–1 mg template DNA in 50-ml Virus Replication after Transfection of Cells with Proviral DNAs
reactions in buffer (40 mM Tris–Cl (pH 8), 8 mM MgCl2 , Containing CA Mutationsa
2 mM spermidine, 50 mM NaCl, 10 mM DTT, 400 mM
DNA NIH/3T3 BALB/ceach of ATP, UTP, and GTP, and 100 mCi [a-32P]CTP (800
Ci/mmol)) containing 10 U T3 RNA polymerase and 40 U
pNCA (wt) / /
placental ribonuclease inhibitor. Synthesis was carried A110T { /
out for 30–60 min at 377. Template DNA was removed A110V / /
A129T / /by addition of 10 U RNase-free DNase I for 15 min at
G145Q / /377, and the RNA was recovered by phenol/chloroform
H114Y / /extraction and two ethanol precipitations and resus-
P146L / /
pended in TE. The resulting radiolabeled plus strand RNA R131K / /
probe could hybridize to various minus-strand viral R156K / /
V139I / /DNAs, and after RNase treatment yielded labeled prod-
T108I/T143I / ntucts of distinctive sizes for minus-strand strong stop DNA
A124T/G145E / /(145 nt), translocated products (185 nt), and full-length
L122F 0 0
complete minus strand DNA (242 nt). A137V 0 0
P150L 0 0
P102S 0 ntAnalysis of viral DNA synthesized by virions in vitro.
P102S/A129V 0 nt
Endogenous reverse transcription reactions were G111D/V139I 0 nt
P146L/S149F 0 ntused to detect the synthesis of minus-strand strong-stop
H114Y/S151L 0 ntDNA. Virus was harvested from cells at 12-hr intervals,
H117Y/A129V 0 0pelleted (25,000 rpm, 3 hr at 47) and then resuspended
P102L/T143I 0 0
in TNE buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 150 mM R119C/P133S 0 nt
NaCl). The virions were purified further by centrifugation G130N 0 0
P150S 0 0(25,000 rpm in an SW41 rotor for 6–12 hr) above a 25%/
A129V/P146S 0 045% (wt/vol) sucrose step-gradient, collected from the
G130S/G141K 0 0interface, and further concentrated after dilution by cen-
G130S/R156K 0 0
trifugation (25,000 rpm, 3 hr at 47). Virions were sus- R119C/P133L 0 0
pended in TNE buffer and stored at 0707. Concentrated
a Virus was monitored by release of virion-associated RT into the cul-virions were incubated in buffer (50 mM NaCl, 6 mM
ture medium. /, high levels of RT; 0, no RT; {, reduced levels of RT.MgCl2 , 1 mM dithiothreitol, 0.01% Nonidet P-40, 50 mM
Tris–HCl, pH 8.0) containing three unlabeled deoxyribo-
nucleoside triphosphates (2 mM each) and [32P]dTTP (1 analysis. A total of 28 mutants were generated, with sub-
mM, 1 Ci/mmol) at 377 for 30 min. Reaction products stitutions scattered throughout the central portion of CA
were phenol extracted, ethanol precipitated, and treated (Fig. 1). Each mutant contained one or two substitutions
with 0.33 N NaOH at 557 for 20 min and finally analyzed (listed in Table 1).
on 7.5% denaturing polyacrylamide gels. A DNA fragment (XhoI to BclI) from each mutant was
Reverse transcriptase activity on exogenous templates subcloned into the wild-type clone pNCA for biological
was assayed by the rapid dot method (Goff et al., 1981). testing, to eliminate mutations that might have been inad-
vertently created in other regions of the viral genome.
RESULTS Each DNA was used to transform NIH/3T3 cells to induce
transient expression of viral RNAs and proteins, and theViability of M-MuLV gag mutants
cultures were monitored for the spread of replication-
competent virus by reverse transcriptase assays of cul-To define the role of the capsid protein in the pro-
cesses of M-MuLV virus assembly and infectivity, random ture medium (Fig. 2A). Eleven of the 28 mutant DNAs
yielded virus with replication properties essentially indis-point mutations were introduced into the central portion
of the capsid (CA/p30) region in an otherwise wild-type tinguishable from the wild type (Table 1); mutant A110T
was marginally reduced. The remaining 17 DNAs wereM-MuLV provirus. Heteroduplex molecules between a
wild-type plasmid (pNCA) and a deletion mutant (termed completely inactive and did not induce the formation of
replication-competent virus.Dx/a) were generated to form a single-stranded loop in
the CA region, and sequences in the loop were mutagen- Some of these CA mutations lie in a region which
determines the NB tropism of the MuLVs: that is, theized by exposure to bisulfite. The DNA was then intro-
duced into bacteria, and DNAs from individual clones ability of the viruses to replicate in cells expressing par-
ticular alleles of the Fv-1 locus on chromosome 4 (Des-were screened first by gel electrophoresis after restric-
tion endonuclease digestion, and then by DNA sequence Groseillers and Jolicoeur, 1983; Jolicoeur, 1979; Ou,
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FIG. 2. Infectivity of M-MuLV capsid point mutants. Cells were transiently transfected with the indicated M-MuLV mutant proviral DNAs, and
conditioned medium was collected at the indicated days posttransfection. Samples were assayed for reverse transcriptase activity by the rapid dot
method. (A) Assays in NIH/3T3 cells. (B) BALB/c 3T3 cells.
FIG. 3. Immunoprecipitation of virion-associated CA protein released by COS-1 cells after transfection with mutant proviral DNAs. COS-1 cells
were transfected with the indicated viral DNAs, and at 48 hr posttransfection cultures were metabolically labeled for 12 hr with [35S]methionine.
Virions were isolated and the CA protein was immunoprecipitated with anti-Moloney serum and analyzed by SDS–PAGE and fluorography. The
mutants from two gels are shown in two panels. The position of migration of marker proteins is indicated at the left and of CA protein at the right.
Control, no DNA was added.
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TABLE 21983). In particular, N-tropic viruses replicate on cells of
Fv-1n/n genotype; B-tropic viruses replicate on cells of Fv- Assembly and Release of Mutant Virion Particles
1b/b genotype; and NB-tropic viruses, including Moloney
Cell linesMuLV, can replicate on either. To test whether the CA
mutations altered the NB tropism of the parental virus,
COSathe DNAs of selected mutants were introduced into Balb/
c 3T3 cells (genotype Fv-1b/b), and the ability of the vi- DNA IPb Westernc NIH/3T3d
ruses to replicate was assessed by RT assay as before.
pNCA (wt) / / /All of the mutants tested showed the same ability to
P102S / / /replicate in BALB/c cells as in NIH/3T3 cells (Fig. 2B;
A110T / / /Table 1), though mutant A110T was slightly more active
L122F / / /
in BALB/c cells. Thus, there were no strong host range A137V low / /
effects and no apparent changes in tropism induced by P150L low / /
P102L/T143I / / /the mutations.
P102S/A129V / / /
G111D/V139I / / /
Expression and assembly of M-MuLV gag mutants H114Y/S151L / / /
H117Y/A129V / / /
To examine the effects of the CA mutations on particle P146L/S149F / / /
R119C/P133L 0 0 ntformation and release, each mutation was transferred to
plasmid pSV-NCA, containing the SV40 origin of replica-
a Cos cells were transfected with proviral DNA constructs containingtion, to provide for amplification of the DNA to high copy
the SV40 origin of replication, and release of virions was assessed
number in SV40 T antigen-expressing COS-1 cells. The after 48 hr.
mutant DNAs were introduced into COS-1 cells, and after b Virions were detected by immunoprecipitation of pelletable proteins
from culture medium with anti-Gag antiserum after metabolic labeling48 hr the cells were metabolically labeled overnight with
of the cells. Entries marked low showed consistently reduced levels[35S]methionine. The culture medium from each sample
of Gag proteins across several experiments.was harvested, and the virions were isolated by centrifu- c Virions were detected by Western blots of unlabeled proteins pel-
gation and lysed with detergent. The labeled virion pro- leted from culture medium using Gag antiserum.
teins were immunoprecipitated with polyclonal rabbit d Stable producer cell lines were derived by cotransformation of NIH/
3T3 cells with proviral DNAs and selectable marker DNAs. Virion re-anti-CA antiserum and analyzed by SDS–gel electropho-
lease was assessed by Western blot.resis and fluorography. The mature Gag protein CA (p30)
was detected in the medium of wild-type virus, and com-
parable levels of CA were detected for nearly all the
companying reductions in mature CA, and in the case ofmutants tested (Fig. 3; summarized in Table 2). Mutant
P146L/S149F, P150L, and L122F, there was increasedR119C/P133L was consistently negative for release of
accumulation of a processing intermediate migrating atCA, and A137V and P150L showed only low levels of
about 55 kDa. This intermediate could consist of p12-CA (roughly 10-fold less) across several experiments. To
CA-NC or MA-p12-CA. These three mutants thus showconfirm these results, similar virion preparations were
slightly delayed processing and perhaps with selectivityharvested and purified from unlabeled cultures, and the
for particular cleavage sites in Gag.virion proteins were analyzed after electrophoresis by
Mutations have been found sometimes to produce dif-Western blots using the same antiserum. As before,
ferent phenotypes in analyses at very high levels of ex-nearly all the mutants produced normal levels of virion-
pression in COS cells, as compared with analysis atassociated Gag proteins (Fig. 4; Table 2). Mutant R119C/
lower levels in other cell types; presumably the higherP133L was again negative, suggesting a significant block
level of expression can override or mask subtle effectsto assembly. Mutant A137V now showed nearly normal
of some mutations (Berkowitz and Goff, 1993; Granowitzlevels of Gag-related material, suggesting that the low
and Goff, 1994). To test for virus assembly in a settinglevels seen in the immunoprecipitation experiments re-
without DNA amplification, stable rodent cell lines ex-flected difficulty in recognition of the mutant protein by
pressing the mutant viral DNAs were also constructedthe antisera or difficulty in recovery of the protein; based
and analyzed for virion production. NIH/3T3 and Rat2on the blots, this mutant was scored as assembly-compe-
cells were cotransformed with the mutated pNCA deriva-tent (Table 2). In these experiments, the precursor
tives and pSV2neo or pSV2his plasmids, and trans-Pr65gag protein can often be detected better than in
formants were selected with G418 and histidinol, respec-immunoprecipitations, presumably because important
tively. The resulting clones were picked and expandedepitopes are available after the gel. Significant levels of
into clonal cell lines. Potential stable producer cells wereunprocessed Pr65gag precursor protein could be detected
screened for expression of Pr65gag by immunoprecipita-for the wild type and many of the mutants. Virions of
tion of cell lysates after [35S]methionine labeling. Linesmutants P146L/S149F and A137V seemed to contain a
higher proportion of Pr65gag than the wild type with ac- expressing a majority of the mutant proviruses were suc-
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FIG. 4. Western blot analysis of virion-associated Gag proteins produced by COS-1 cells. COS-1 cells were transiently transfected with the
indicated proviral mutants, and viral supernatants were collected 48–72 hr posttransfection. Virions were isolated and analyzed by Western blot
using anti-CA serum. (A) Migration of capsid protein (CA), full-length Pr65gag, and a proteolytic processing intermediate are indicated at the left.
Control, No DNA added. (B) Upper band is nonspecific.
cessfully identified. To test for virion release, the cultures with nucleotides and detergent (the so-called ‘‘endoge-
were labeled overnight with [35S]methionine and pelleted nous reaction’’; Rothenberg et al., 1977; Gilboa et al.,
supernatants were immunoprecipitated using a CA-spe- 1980). The major DNA products detected at short reac-
cific serum. In all cases, similar results were obtained tion times are minus strand species: the strong stop DNA
as for virus analyzed from COS cell transfections (data intermediate made at the 5* end of the genome, plus a
not shown). Similarly, Western analysis of pelleted super- heterogeneous mixture of longer DNAs formed by its
natants harvested from unlabeled mutant producer lines elongation after strong stop translocation to the 3* end
showed the presence of CA in all mutants that were of the genome (for review see Telesnitsky and Goff,
positive in COS cells (examples in Fig. 5). Thus, the re- 1993). To determine whether the mutant virions were
lease of virions by the COS cells was not an artifact of capable of carrying out such DNA synthesis, multiple
the overexpression of Gag protein, but for these mutants harvests were collected from a few of the stable virus
was a good reflection of assembly as it occurred in ro- producer lines, and virions were purified, concentrated,
dent cells as well. and incubated with labeled nucleotides. RNA was re-
moved by treatment with alkali, and the labeled viral DNA
Viral DNA synthesis by virions in vitro
products were analyzed by electrophoresis on polyacryl-
Wild-type virions can be induced to initiate reverse amide gels followed by autoradiography (Fig. 6). All mu-
transcription of the genomic RNA in vitro by incubation tant virions tested were capable of forming minus strand
strong stop and extended products in this reaction (Table
3). The variability in the amount of total DNA synthesized
by the preparations correlated roughly with the amount
of input virions as determined by measurement of the
virion-associated reverse transcriptase activity on exoge-
nous synthetic templates. These results suggest that in
all the mutants tested, genomic RNA was packaged, the
tRNA primer was annealed to the genome, and reverse
transcriptase was incorporated into the virions. There
were no striking effects of any of the mutations on the
initiation of DNA synthesis after permeabilization with
detergent. For some of the mutants (P146L/S149F andFIG. 5. Western blot analysis of virion-associated CA proteins re-
leased by stable NIH/3T3-derived virus-producing cell lines. Culture P102S/A129), there was a much lower level of elongated
medium was harvested from stable cell lines expressing the indicated products as compared with the levels of strong stop DNA.
viral mutants, and the virions were pelleted by centrifugation. Virion Thus, for these mutants, there may have been a defectproteins were resuspended and analyzed by Western blot using anti-
in strong stop DNA translocation. An alternative explana-capsid serum. The position of migration of capsid protein (CA) is indi-
cated. tion is that these mutant virions were detergent sensitive;
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FIG. 6. Endogenous reaction products from mutant virions. Virions were harvested from NIH/3T3 cell lines releasing the indicated mutants and
assayed for their ability to mediate DNA synthesis in vitro from added nucleotides, using the endogenous RNA genome as template. Labeled
product DNA was treated with RNase and analyzed by gel electrophoresis followed by autoradiography. The position of migration of minus-strand
strong-stop DNA and extended products are indicated. The origin of the doublet of strong stop species is unclear. Wild type represents a true wild-
type virus preparation, while Rev (wt) indicates a wild-type virus stock derived from reversion of a point mutant. The position of migration and length
of marker DNAs are indicated at the right. Panels represent two experiments.
disruption of the integrity of the virion core has been DNA could be detected after infection with any of the
replication-defective mutant virions (examples shown insuggested to block translocation (Rothenberg and Balti-
more, 1977). Fig. 7A; summarized in Table 3). These data suggest that
the course of the infection for these mutants was blocked
at a very early stage, either before or during reverseSynthesis of viral DNA in infected cells
transcription of the viral RNA.
One of the first steps in infection by retroviruses is Harvests from many of the mutant producer lines con-
reverse transcription of its genomic RNA into DNA. To tained 2- to 10-fold lower levels of virus than the wild-type
determine whether the mutant virions could synthesize preparations, as estimated by RT assay on exogenous
DNA in vivo, mutant virions were harvested from pro- templates. To test whether viral DNA could be detected
ducer cells and used without dilution to infect fresh NIH/ with these lower levels of virus, infections were also
3T3 cells. After 12–16 hr, the low-molecular-weight DNA carried out with 10- and 100-fold dilutions of wild type.
was isolated by the Hirt extraction method (Hirt, 1967), The viral DNA isolated from these diluted infections could
separated by gel electrophoresis, and blotted to nylon, readily be detected on Southern blots at 10-fold dilution,
and the viral DNA was detected by hybridization with a and on the original films at 100-fold. (Fig. 7B). These
labeled M-MuLV DNA probe. All three viral DNA forms— results suggest that the mutants were at least 10-fold
circles with either one or two LTRs and full-length linear reduced in their ability to synthesize viral DNAs in vivo.
DNAs—were present in cells infected with wild-type M- Southern blot analysis permits detection of full-length
MuLV. When these DNAs were subjected to digestion viral DNAs, but probably would not detect incomplete
with HindIII, which cleaves the genome once in the pol products of reverse transcription. To test whether the
gene, the circular viral DNAs were linearized to give 8.8- mutant virions could initiate DNA synthesis and form het-
and 8.2-kb DNAs, and the linear form was broken into erogeneous DNA intermediates, an RNase protection
assay for viral DNA was devised. A radiolabeled plus5.3- and 3.5-kb fragments, as expected (Fig. 7). No viral
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TABLE 3 that the intermediate does not accumulate to detectable
levels. This species can be detected after infection withViral DNA Synthesis Mediated by Mutant Virion Particles
a mutant virus defective in the RNase H function of RT,
Viral DNA synthesis in which translocation is specifically blocked (Blain and
Goff, 1995), and in endogenous reverse transcription re-
in vivob actions carried out in vitro with this mutant (Fig. 8B).
RNase protection assays after infection with five of theDNA in vitroa By blot By RNase protection
CA mutants (L122F, H114Y/S151L, P102S/A129V, P102S,
pNCA (wt) / / / and P146L/S149F; examples shown in Fig. 8B; summa-
A110T nt / / rized in Table 3) showed that none of these mutants were
P102S / 0 0 capable of making any detectable viral DNA. Mutant
L122F / 0 0
A110T, a viable mutant with reduced levels of virus pro-P150L nt 0 0
duction (Table 1), showed readily detectable formationP102S/A129V / 0 0
G111D/V139I / 0 0 of viral DNA. Thus, the defective mutants were blocked
H114Y/S151L / 0 0 at a very early stage in the infection, before even minus
P146L/S149F / 0 0 strand strong stop DNA was synthesized.
a The indicated mutant virion particles were harvested from producer
cell lines and tested for their ability to mediate synthesis of viral DNA Complementation of virus replication by Gag
in vitro from the endogenous RNA template. expression provided by the M23 cell line
b The mutant viruses were used to acutely infect NIH/3T3 cells, and
their ability to synthesize viral DNA was assessed either by Southern The M23 cell line is an NIH/3T3 line containing a de-
blot or by RNase protection assay. fective M-MuLV provirus expressing only the Gag poly-
protein but not the Gag-pol or Env gene products; the
line releases uninfectious particles lacking both reversestrand RNA probe was prepared spanning the U5, R,
U3, and pbs regions; minus strand strong stop DNA, transcriptase and envelope glycoproteins (Shields et al.,
1978). Mutant viral DNAs that can provide the missingtranslocated minus strands, and completed minus strand
products would anneal to this probe and would protect Gag-pol and env functions can initiate virus replication
in this host by complementation. Once virus replicationRNA fragments of distinct sizes from RNAse digestion
(Fig. 8A). Low molecular weight DNAs were prepared begins, the spreading virus quickly recombines to form
wild-type virus that can be detected by monitoring RTafter infection of NIH/3T3 cells by the mutant virions as
before and then hybridized to the probe. The mixtures activity in the culture media (Crawford and Goff, 1984;
Schwartzberg et al., 1984). Each of the mutant DNAswere treated with RNase and the products analyzed by
polyacrylamide gel electrophoresis. DNAs from a wild- were transfected into M23 cells by the DEAE-dextran
procedure, the cultures were passaged, and the superna-type infection protected fragments migrating at 185 and
242 nt, corresponding to the translocated and complete tant was assayed for reverse transcriptase activity (Fig.
9). Only two of the mutants, P146L/S149F and G111D/minus strand DNA products. The minus strand strong
stop DNA was not detected from a wild-type infection, V139I, were capable of complementing the M23 cell line
(Table 4). The majority of the mutants did not producepresumably because translocation in vivo is so efficient
FIG. 7. Southern blot analysis of synthesis of preintegrative viral DNAs by mutant virus after acute infection of NIH/3T3 cells. (A) NIH/3T3 cells
were acutely infected with the virus preparations harvested from stable cell lines expressing the indicated mutants, and low-molecular weight DNA
was isolated 12–16 hr postinfection. Viral DNA was analyzed by agarose gel electrophoresis followed by Southern blot and detected by hybridization
with a full-length M-MuLV probe. DNAs were analyzed without cleavage (0) or after digestion with HindIII (/). The positions of migration of vDNA
products are indicated at the left: 8.8 kb, full-length linear DNA; 5.3 and 3.5 kb, fragments generated by HindIII digestion of the full-length linear
DNA. (B) The indicated dilutions of wild-type DNA were analyzed to determine the sensitivity of detection of low levels of DNA. Control, no virus.
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FIG. 8. RNase protection assay for incomplete viral DNAs synthesized in acutely infected NIH/3T3 cells. (A) Schematic diagram of the 5* region
of viral DNAs formed during reverse transcription, of the labeled probe used in RNase protection assay, and of the protected RNA fragments
produced by digestion of probe after hybridization. The minus strand strong stop (-SSS) DNA generates a 145-nt protected fragment, the translocated
(jumped) DNA generates a 185-nt protected fragment, and the full-length minus strand DNA generates a 242-nt protected fragment. (B) Polyacrylamide
gel analysis of protected fragments of labeled riboprobe. Cells were infected with the indicated mutant viruses, and low molecular weight DNA
was isolated and used to protect the RNA probe. Position of undigested probe, and of protected fragments produced by full-length minus strand,
‘‘jumped’’, and minus strand strong stop (-SSS) DNAs are indicated. In lanes 6–8, DNA was isolated at the indicated times postinfection. In lane 9,
DNA products were analyzed after isolation from an endogenous reaction performed with virions of mutant D5E, an RNase H mutant which
accumulates -SSS (Blain and Goff, 1995). Control, no virus.
detectable replication-competent virus. These results that the mutant Gag and Gag-pol proteins produced from
the viral DNAs in some way interfere with normal replica-suggest that the CA mutations present in these noncom-
plementing mutants in some way prevent the function of tion functions, even with the wild-type Gag.
the mutant Gag-pol protein, even with a wild-type Gag
provided by the cell line. An alternative explanation is DISCUSSION
The substitution mutations studied here are located
within the central third of CA and include a few within the
major homology region (MHR), highly conserved among
distantly related retroviruses. Random mutagenesis of
this region, generating single and double amino acid
substitutions, gave rise to mutants with a variety of differ-
ent phenotypes. Roughly one-third of the mutations gen-
erated had no apparent effect on viral replication, and
the remaining ones blocked replication both in NIH/3T3
and Balb/c 3T3 cells. Thus, none of the mutants showed
any alteration in the host range of the parental virus, and
in particular no changes in the Fv-1 tropism.
FIG. 9. Complementation assay. M23 cells were transfected with the The results suggest essential roles for the CA domain
indicated proviral DNAs, and culture medium was collected at the during at least two stages in the life cycle. A single mu-
indicated days posttransfection. Samples were assayed for reverse tant, R119C/P133L, was found to be assembly defective
transcriptase activity by the rapid dot method (Goff et al., 1981). CM10
and indicates that some alterations in CA can block theand CM11 are replication-defective mutants containing point mutations
formation and/or release of virion particles. The vast ma-in NC and known to complement the M23 cell line (Meric and Goff,
1989); these cultures were only carried through Day 9. jority of the mutants, however, were assembly-compe-
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TABLE 4 sensitive to disruption. Changing the proline at position
150 to either a leucine or serine renders the virus nonin-Complementation Assay for Gag Function in M23 Cells
fectious. The serine at position 149 seems to be the more
DNA Virus replicationa important of the two altered residues in mutant P146L/
S149F, since the single mutant P146L was viable (Table
pNCA (wt) / 1). Similarly, the serine at position 151 is likely to be
A110T /
the important residue in mutant H114Y/S151L, since theP102S 0
single mutant H114Y was viable. Mutations at these threeL122F 0
A137V 0 residues, as for most of the CA mutations, had no effect
P150L 0 on assembly but blocked early events. The other resi-
P102S/A129V 0 dues mutated in the MHR region (T143I, G145Q/E, P146L,
P102L/T143I 0
and R156K) did not appear to affect replication. It is inter-G111D/V139I /
esting to note that arginine at position 156 is one ofH114Y/S151L 0
H117Y/A129V 0 the absolutely conserved positions in the MHR region.
R119C/P133L 0 Mutation of the homologous residue (R162K) in the Ma-
P146L/S149F / son Pfizer monkey virus (MPMV) prevented replication
(Strambio-de-Castillia and Hunter, 1992), and the pheno-a The indicated mutant DNAs were tested for their ability to initiate
type of the mutant was similar to those of our CA mutants:virus replication in Gag-positive M23 cells, detected by release of RT.
assembly-positive yet noninfectious. In HIV-1, removal of
the extended side chain at this position by replacement
with alanine (R167A) also reduced virus replication with-tent; virion particles were released from producer cells
at normal levels. The mutant virions contained a normal out affecting assembly, though the block was not abso-
lute (Mammano et al., 1994).complement of processed Gag proteins, and contained
genomic RNA, primer tRNA and RT, as judged by their Ten of the CA mutations found to block virus replica-
tion here have been previously tested for their effects onability to mediate reverse transcription of the RNA in the
endogenous reaction in vitro. Both the mutant Gag and Gag-Gag interaction in the yeast two-hybrid system (Alin
and Goff, 1996). Gag precursor proteins containing nearlythe mutant Gag-pol proteins were therefore apparently
incorporated into the virions, with both protease and RT all of these ten mutations were still able to interact in
various combinations either with wild type or anotherbeing enzymatically active. Since the protease at least
requires dimerization for activation, it is likely that the copy of the mutant Gag protein. Some of these mutants
showed complex allele-specific behaviors: some inter-Pol products are incorporated so as to permit normal
dimerization. Treated with detergent and incubated with acted only with the wild type and not with another copy
of the mutant; one (P150L) interacted only with anothertriphosphates, the virions could initiate DNA synthesis
efficiently. In spite of these apparently normal features, copy of the mutant Gag and not with wild-type. These
defects were not apparent at the time of assembly inthe virions were unable to synthesize any detectable viral
DNA in vivo, suggesting a block in the very early stages vivo, because all of these mutants were competent for
formation and release of virions. Thus, the alterations inof infection. This phenotype is reminiscent of those mani-
fest by mutations in other regions of gag (MA, p12, and Gag-gag interactions seen in the yeast system may re-
flect the defects in early steps seen in vivo. There wasCA), which are also blocked at an early stage in the viral
life cycle (Crawford and Goff, 1984; Schwartzberg et al., only one mutant, R119C/P133L, that was completely un-
able to interact with any other Gag in any combination1984). Similar mutants have been identified in MPMV
(Strambio-de-Castillia and Hunter, 1992), RSV (Wills and (misidentified in the original report as R119C/P146S, sub-
sequently corrected). Interestingly, this was the singleCraven, 1991), and HIV (Mammano et al., 1994). The
steps most likely affected are immediately after fusion of mutant that was found here to be assembly defective.
This mutant may be a rare example of a truly interaction-the viral and cell membranes, at the time the virion cores
are permeabilized sufficiently to allow entry of triphos- negative Gag.
The vast majority of earlier Gag mutants show a goodphates for DNA synthesis. Essentially nothing is known
about this step in the life cycle for any retrovirus. It is concordance between their ability to assemble virus and
their ability to provide a functional Gag-pol precursorpossible that a special configuration of the virion core is
required for reverse transcription to occur in vivo and protein to the virions assembled with wild-type Gag in
the M23 cell line (Crawford and Goff, 1984; Schwartzbergthat the CA mutations disrupt this configuration. In an
extreme example of such a disruption, it is possible that et al., 1984). Thus, those mutants that were assembly-
competent on their own (e.g., mutations in p12 or NC)the mutant capsids may fall apart too completely or too
soon. generally complemented M23 cells; those that were as-
sembly defective (e.g., some deletion mutations in CA)Several of the mutations studied fall within the major
homology region of the capsid protein. A cluster of three did not. This observation suggests that the requirements
for virion assembly per se are closely related to the re-amino acids (S149, P150, and S151) may be particularly
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